Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingMay 15, 2024Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitBreckenridge Pharmaceutical, Inc · D-0484-2024Class IIOngoingMay 15, 2024Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitBreckenridge Pharmaceutical, Inc · D-0483-2024Class IIOngoingMay 15, 2024Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitBreckenridge Pharmaceutical, Inc · D-0482-2024Class IIICompletedMay 8, 2024Valacyclovir Tablets USPFailed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.Viatris Inc · D-0481-2024Class IIICompletedMay 8, 2024Fentanyl 1000mcg/100mLLabeling: Wrong BarcodeHikma Injectables USA Inc · D-0480-2024Class IITerminatedMay 8, 2024EYLEA, (aflibercept) InjectionLack of Assurance of Sterility: Complaints of syringe breakageRegeneron Pharmaceuticals Inc · D-0479-2024Class IIIOngoingMay 8, 2024Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-FreeOut of specification for assayImprimis NJOF, LLC · D-0478-2024Class IICompletedMay 8, 2024Methylergonovine Maleate TabletsFailed Dissolution SpecificationsAmneal Pharmaceuticals of New York, LLC · D-0477-2024Class IIOngoingMay 8, 2024Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%Subpotent DrugImprimis NJOF, LLC · D-0476-2024Class IITerminatedMay 1, 2024minoliraCGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that...EPI Health, LLC · D-0475-2024Class IITerminatedMay 1, 2024minoliraCGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that...EPI Health, LLC · D-0474-2024Class IITerminatedMay 1, 2024ClodermCGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that...EPI Health, LLC · D-0473-2024Class IIOngoingMay 1, 2024Diltiazem Hydrochloride Extended-Release CapsulesFailed Dissolution SpecificationsGlenmark Pharmaceuticals Inc., USA · D-0472-2024Class IITerminatedMay 1, 2024Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USPShort fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.Cipla USA, Inc. · D-0471-2024Class ITerminatedMay 1, 2024ForeverMen Natural Energy Boost CapsulesMarketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual...FA Online Inc · D-0470-2024Class IIIOngoingMay 1, 2024AbilifyCross Contamination with Other ProductsSecond Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · D-0469-2024Class IIIOngoingMay 1, 2024AbilifyCross Contamination with Other ProductsSecond Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · D-0468-2024Class IIIOngoingMay 1, 2024AbilifyCross Contamination with Other ProductsSecond Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · D-0467-2024Class IIIOngoingMay 1, 2024AbilifyCross Contamination with Other ProductsSecond Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · D-0466-2024Class IIOngoingMay 1, 2024FUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mgFailed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in...Nomax Inc · D-0465-2024Class IIOngoingMay 1, 2024FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USPFailed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in...Nomax Inc · D-0464-2024Class IIOngoingMay 1, 2024GloStripsFailed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in...Nomax Inc · D-0463-2024Class IIOngoingMay 1, 2024GloStripsFailed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in...Nomax Inc · D-0462-2024Class IITerminatedMay 1, 2024EyesalineCGMP DeviationsHoneywell Inc · D-0461-2024Class IOngoingMay 1, 2024Aruba Aloe Hand Sanitizer GelChemical Contamination: Product manufactured with ethanol API that contains methanolAruba Aloe Balm N.V. · D-0460-2024Class IOngoingMay 1, 2024Alcoholada GelChemical Contamination: Product manufactured with ethanol API that contains methanolAruba Aloe Balm N.V. · D-0459-2024Class IOngoingMay 1, 2024HONEY MANUKA BUNNY LOVEMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0458-2024Class IOngoingMay 1, 2024ALPHASTRIP MALE PERFORMANCE ENHANCERMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0457-2024Class IOngoingMay 1, 2024The GOAT SUBLINGUAL STRIPMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0456-2024Class IOngoingMay 1, 2024SILVERBACK XXX POWER MALE ENHANCEMENTMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0455-2024Class IOngoingMay 1, 2024libigrow RED DRAGON+Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0454-2024Class IOngoingMay 1, 2024GoHARD 25000Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0453-2024Class IOngoingMay 1, 2024Pink Pussycat HoneyMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0452-2024Class IOngoingMay 1, 2024Samurai-X Honey 6800Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0451-2024Class IOngoingMay 1, 2024Flower PowerMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0450-2024Class IOngoingMay 1, 2024Weiner Boner HoneyMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0449-2024Class IOngoingMay 1, 2024Spanish Fly 22K capsulesMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.Pyramids Wholesale Inc. · D-0448-2024Class IICompletedApr 24, 2024S.P LabsFailed Stability SpecificationsSpecialty Process Labs LLC · D-0447-2024Class IICompletedApr 24, 2024S.P.LabsFailed Stability SpecificationsSpecialty Process Labs LLC · D-0446-2024Class IICompletedApr 24, 2024Sterile DiluentCGMP DeviationsEli Lilly & Company · D-0445-2024